SCHEMBL17599404

SCHEMBL17599404

Cc1ccc(Cl)cc1S(=O)(=O)Nc1ccc(-c2cccc(C(=O)O)c2)c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
GAA P10253 2/20 0.48
RAD52 P43351 1/20 0.48
G6PD P11413 1/20 0.48
SERPINE1 P05121 1/20 0.48
SLC16A3 O15427 2/20 0.47
USP2 O75604 1/20 0.47
MCL1 Q07820 1/20 0.47
HTT P42858 2/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
FABP4 P15090 1/20 0.45
LMNA P02545 1/20 0.45
ACLY P53396 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599340 0.90 SLC16A3 (0.58) KMT2AMEN1SERPINE1SLC16A3USP2
SCHEMBL17599360 0.88 ITGA1 (0.56) KMT2AMEN1SERPINE1SLC16A3MCL1
SCHEMBL17599371 0.86 KMT2A (0.51) KMT2AMEN1SLC16A3MCL1HTT
SCHEMBL17599301 0.85 KMT2A (0.48) KMT2AMEN1GAARAD52G6PD
SCHEMBL17599333 0.85 PTK2B (0.52) KMT2AMEN1GAARAD52G6PD
SCHEMBL17599403 0.84 WDR5 (0.49) KMT2AMEN1SLC16A3MCL1FABP4
SCHEMBL17599368 0.82 KDM4E (0.48) KMT2AMEN1SERPINE1SLC16A3MCL1
SCHEMBL17599379 0.82 ACLY (0.54) KMT2AMEN1SLC16A3FABP4ACLY
SCHEMBL17599382 0.82 WDR5 (0.45) KMT2AMEN1SERPINE1SLC16A3MCL1
SCHEMBL17599353 0.82 ACLY (0.58) KMT2ASERPINE1MCL1ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed